Intensive insulin therapy significantly reduced the long-term incidence and cost of ocular surgery in patients with type 1 diabetes, according to an analysis of data from the Diabetes Control and Complications Trial.The trial included 1,441 patients wi…
NovaBay Pharmaceuticals to Feature Key Opinion Leaders in Ophthalmology and Optometry at Analyst and Investor Day Event on May 19
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals Features Key Opinion Leaders in Ophthalmology and Optometry in Analyst and Investor Day Event on May 19
Isarna Presents Positive Preclinical Results Supporting Development of ISTH0036 for the Treatment of Glaucoma
MUNICH–(BUSINESS WIRE)–Our preclinical data support the compound’s potential to protect glaucoma patients’ vision and we see other high medical need diseases that could potentially benefit from TGF-β-targeted treatment.
Live Ebola virus detected in survivor’s eye months after recovery
A doctor treated for acute Ebola virus disease he contracted at a treatment center in Sierra Leone was found to have viable virus in the fluid inside an eye months after recovery.
Good results seen in prospective study of transepithelial PRK
PARIS — Transepithelial PRK leads to a faster recovery with a low risk of complications, according to one surgeon.TransPRK (Schwind) is a one-step no-touch surface ablation technique based on a classic PRK profile with the addition of an epithelial component, Amine Chachoua, MD, explained at the meeting of the French Society of Ophthalmology. The epithelium is included in the laser ablation profile, avoiding contact of the eye with instruments.
Roche announces FDA approval of cobas KRAS Mutation Test for diagnostic use
Roche today announced that the U.S. Food and Drug Administration has approved the cobas KRAS Mutation Test for diagnostic use. The real-time PCR test is designed to identify KRAS mutations in tumor samples from metastatic colorectal cancer (mCRC) patie…